Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jin Li
Shanghai East Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Provincial Hospital
Hefei, Anhui, China
- Beijing Cancer Hospital
Beijing, Beijing Municipality, China
- Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
- Henan Cancer Hospital
Zhengzhou, Henan, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- Xiangya Hospital Central South University
Changsha, Hunan, China
- Huaihua Second People'S Hospital
Huaihua, Hunan, China
- Linyi Cancer Hospital
Linyi, Shandong, China
- Shanghai East Hospital
Shanghai, Shanghai Municipality, China
- Zhongshan Hospital, Zhongshan University
Shanghai, Shanghai Municipality, China
- Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
- the First Affiliated Hospital, Zhejiang University
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jun 2020
- Primary completion
- 8 Jul 2023
- Completion
- 28 Sept 2023
- Last update posted
- 24 May 2024
- Registered enrollment
- 62
- Registry id
- NCT04400383
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.